drugset / Trial / NCT00650195
Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study was to investigate the bioequivalence of Mylan metolazone 10 mg tablets to Celltech Zaroxolyn® 10 mg tablets following a single, oral 10 mg (1 x 10 mg) dose administration under fasting conditions.
Timeline
- Start
- 2004-02
- Primary completion
- 2004-02
- Completion
- 2004-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metolazone | Small molecule | 10 mg | Oral |
Indications
No indication recorded.